Evidence map›Paper›PMID 31620209›Full record

ArticleAnnals of thoracic medicine

Diagnosis of infectious pleural effusion using predictive models based on pleural fluid biomarkers.

Lucía Ferreiro, Óscar Lado-Baleato, Juan Suárez-Antelo, María Elena Toubes, María Esther San José, Adriana Lama, Nuria Rodríguez-Núñez, José Manuel Álvarez-Dobaño, Francisco J González-Barcala, Jorge Ricoy and 2 more

Abstract read
In one paragraph

Article in Annals of thoracic medicine. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Lucía FerreiroDepartment of Pulmonology, University Clinical Hospital of Santiago, Santiago de Compostela, Spain.
Óscar Lado-BaleatoDepartment of Clinical Epidemiology, University Clinical Hospital of Santiago, Santiago de Compostela, Spain.
Juan Suárez-AnteloDepartment of Pulmonology, University Clinical Hospital of Santiago, Santiago de Compostela, Spain.
María Elena ToubesDepartment of Pulmonology, University Clinical Hospital of Santiago, Santiago de Compostela, Spain.
María Esther San JoséInterdisciplinary Research Group in Pulmonology, Santiago de Compostela, Spain.
Adriana LamaDepartment of Pulmonology, University Clinical Hospital of Santiago, Santiago de Compostela, Spain.
Nuria Rodríguez-NúñezDepartment of Pulmonology, University Clinical Hospital of Santiago, Santiago de Compostela, Spain.
José Manuel Álvarez-DobañoDepartment of Pulmonology, University Clinical Hospital of Santiago, Santiago de Compostela, Spain.
Francisco J González-BarcalaDepartment of Pulmonology, University Clinical Hospital of Santiago, Santiago de Compostela, Spain.
Jorge RicoyDepartment of Pulmonology, University Clinical Hospital of Santiago, Santiago de Compostela, Spain.
Francisco GudeDepartment of Clinical Epidemiology, University Clinical Hospital of Santiago, Santiago de Compostela, Spain.
Luis ValdésDepartment of Pulmonology, University Clinical Hospital of Santiago, Santiago de Compostela, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionDiagnosis of pleural infection (PI) may be challenging. The purpose of this paper is to develop and validate a clinical prediction model for the diagnosis of PI based on pleural fluid (PF) biomarkers.

methodsA prospective study was conducted on pleural effusion. Logistic regression was used to estimate the likelihood of having PI. Two models were built using PF biomarkers. The power of discrimination (area under the curve) and calibration of the two models were evaluated.

resultsThe sample was composed of 706 pleural effusion (248 malignant; 28 tuberculous; 177 infectious; 48 miscellaneous exudates; and 212 transudates). Areas under the curve for Model 1 (leukocytes, percentage of neutrophils, and C-reactive protein) and Model 2 (the same markers plus interleukin-6 [IL-6]) were 0.896 and 0.909, respectively (not significant differences). However, both models showed higher capacity of discrimination than their biomarkers when used separately (

conclusionsThe two predictive models developed for IPE showed a good diagnostic performance, superior to that of any of the markers when used separately. Although IL-6 contributes a slight greater capacity of discrimination to the model that includes it, its routine determination does not seem justified.

Indexed as

Diagnosticinflammatory biomarkerspleural effusionpleural fluidpleural infection

Identifiers

PMID31620209
PMCPMC6784446

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.